Chancery Upholds AbbVie Damages In Takeda-Lupron Suit
By Leslie A. Pappas · September 5, 2023, 8:50 PM EDT
Delaware's Court of Chancery on Tuesday largely upheld AbbVie's $480.7 million damage request in its dispute with Takeda Pharmaceutical Co. Ltd. over 2019 supply disruptions of the cancer drug Lupron Depot,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login